A 5-year prospective study of the late resolution of chronic hepatitis C after antiviral therapy

Brigida Eleonora Annicchiarico; Massimo Siciliano; Alfonso Wolfango Avolio; Rita Luciana Grillo; G. Bombardieri

doi:10.1111/j.1365-2036.2007.03295.x

A 5-year prospective study of the late resolution of chronic hepatitis C after antiviral therapy

Brigida Eleonora Annicchiarico, Massimo Siciliano, Alfonso Wolfango Avolio, Rita Luciana Grillo, G. Bombardieri

Risultato della ricerca: Contributo in rivista › Articolo in rivista › peer review

5 Citazioni (Scopus)

Abstract

Persistence of hepatitis C virus (HCV) in serum is assured after any course of antiviral therapy that failed to obtain a sustained virological response.

Lingua originale	English
pagine (da-a)	1039-1046
Numero di pagine	8
Rivista	ALIMENTARY PHARMACOLOGY & THERAPEUTICS
Volume	25
DOI	https://doi.org/10.1111/j.1365-2036.2007.03295.x
Stato di pubblicazione	Pubblicato - 2007

Keywords

Adult
Aged
Antiviral Agents
Case-Control Studies
Drug Therapy, Combination
Female
Hepacivirus
Hepatitis C, Chronic
Humans
Interferon-gamma
Male
Middle Aged
Prospective Studies
RNA, Viral
Recurrence
Ribavirin
Treatment Outcome

OSS delle Nazioni Unite

Questo processo contribuisce al raggiungimento dei seguenti obiettivi di sviluppo sostenibile

Accesso al documento

10.1111/j.1365-2036.2007.03295.x

Altri file e collegamenti

Link a IRIS PubliCatt

Cita questo

@article{92af912a2b334fd1b8d0a4ab108ce84a,

title = "A 5-year prospective study of the late resolution of chronic hepatitis C after antiviral therapy",

abstract = "Persistence of hepatitis C virus (HCV) in serum is assured after any course of antiviral therapy that failed to obtain a sustained virological response.",

keywords = "Adult, Aged, Antiviral Agents, Case-Control Studies, Drug Therapy, Combination, Female, Hepacivirus, Hepatitis C, Chronic, Humans, Interferon-gamma, Male, Middle Aged, Prospective Studies, RNA, Viral, Recurrence, Ribavirin, Treatment Outcome, Adult, Aged, Antiviral Agents, Case-Control Studies, Drug Therapy, Combination, Female, Hepacivirus, Hepatitis C, Chronic, Humans, Interferon-gamma, Male, Middle Aged, Prospective Studies, RNA, Viral, Recurrence, Ribavirin, Treatment Outcome",

author = "Annicchiarico, {Brigida Eleonora} and Massimo Siciliano and Avolio, {Alfonso Wolfango} and Grillo, {Rita Luciana} and G. Bombardieri",

year = "2007",

doi = "10.1111/j.1365-2036.2007.03295.x",

language = "English",

volume = "25",

pages = "1039--1046",

journal = "ALIMENTARY PHARMACOLOGY & THERAPEUTICS",

issn = "0269-2813",

publisher = "Blackwell Science Limited:PO Box 88, Oxford OX2 0NE United Kingdom:011 44 1865 776868, 011 44 1865 206038, EMAIL: [email protected], INTERNET: http://www.blackwell-science.com, Fax: 011 44 1865 721205",

}

TY - JOUR

T1 - A 5-year prospective study of the late resolution of chronic hepatitis C after antiviral therapy

AU - Annicchiarico, Brigida Eleonora

AU - Siciliano, Massimo

AU - Avolio, Alfonso Wolfango

AU - Grillo, Rita Luciana

AU - Bombardieri, G.

PY - 2007

Y1 - 2007

N2 - Persistence of hepatitis C virus (HCV) in serum is assured after any course of antiviral therapy that failed to obtain a sustained virological response.

AB - Persistence of hepatitis C virus (HCV) in serum is assured after any course of antiviral therapy that failed to obtain a sustained virological response.

KW - Adult

KW - Aged

KW - Antiviral Agents

KW - Case-Control Studies

KW - Drug Therapy, Combination

KW - Female

KW - Hepacivirus

KW - Hepatitis C, Chronic

KW - Humans

KW - Interferon-gamma

KW - Male

KW - Middle Aged

KW - Prospective Studies

KW - RNA, Viral

KW - Recurrence

KW - Ribavirin

KW - Treatment Outcome

KW - Adult

KW - Aged

KW - Antiviral Agents

KW - Case-Control Studies

KW - Drug Therapy, Combination

KW - Female

KW - Hepacivirus

KW - Hepatitis C, Chronic

KW - Humans

KW - Interferon-gamma

KW - Male

KW - Middle Aged

KW - Prospective Studies

KW - RNA, Viral

KW - Recurrence

KW - Ribavirin

KW - Treatment Outcome

UR - http://hdl.handle.net/10807/37261

U2 - 10.1111/j.1365-2036.2007.03295.x

DO - 10.1111/j.1365-2036.2007.03295.x

M3 - Article

SN - 0269-2813

VL - 25

SP - 1039

EP - 1046

JO - ALIMENTARY PHARMACOLOGY & THERAPEUTICS

JF - ALIMENTARY PHARMACOLOGY & THERAPEUTICS

ER -

A 5-year prospective study of the late resolution of chronic hepatitis C after antiviral therapy

Abstract

Keywords

OSS delle Nazioni Unite

Accesso al documento

Altri file e collegamenti

Fingerprint

Cita questo